Risk management plans and European Union regulatory perspective
This course aims to introduce the different aspects to take into account as philosophical aspects, risk perception concepts but also guidance to take into account as Risk Management Plan for European Medicines Agency, International Committee Harmonization E2E, Committee for Human Medicinal Product guidance and new legislation.
At the end of the course, you will gain knowledge in
Dr. Sabine Straus
Associate professor & Chair of the Pharmacovigilance and Risk Assessment Committee (PRAC)